Securities

Recent Posts

Big Doings in Big Cases: Merck Settle Securities Suits for $688 Million, Facebook IPO Derivative Suits Dismissed
Posted on 15 Feb 2013 by Kevin M. LaCroix

In what may be the largest settlement ever in securities class action litigation involving a pharmaceutical company, Merck has agreed to a combined settlement of $688 million to settle two related securities class action cases. The company's February... Read More

Tags: cholesterol medication , securities class action litigation , Merck

Merck: The Statute of Limitations in Securities Fraud Damage Suits
Posted on 29 Apr 2010 by Thomas O. Gorman

In a result joined by all of the justices, the Supreme Court affirmed the decision of the Third Circuit, concluding that plaintiffs' had timely filed a securities fraud suit against Merck & Co. Merck & Co. v. Reynolds , Case No. 08-905... Read More

Tags: statute of limitations , securities litigation , Vioxx , Merck

Merck To Pay $688M To Settle 2 Securities Class Action Lawsuits
Posted on 14 Feb 2013 by Timothy Raub

WHITEHOUSE STATION, N.J. - (Mealey's) Merck and Co. Inc. will pay $688 million to settle two securities class action lawsuits filed in New Jersey federal court alleging that the drug maker and others failed to disclose adverse results of a clinical... Read More

Tags: cholesterol medication , securities class action litigation , Merck